Cargando…

Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD

OBJECTIVE: To compare the effect of a once-daily extended-release methylphenidate formulation (PRC-063) versus placebo on sleep, measured via daily electronic diary in two clinical trials in pediatric (6–12 years) and adult (≥18 years) patients with attention deficit hyperactivity disorder (ADHD). M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cataldo, Marc, Donnelly, Graeme, Cutler, Andrew J., Childress, Ann, Mikl, Jaromir, Bhaskar, Sailaja, Waxmonsky, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606001/ https://www.ncbi.nlm.nih.gov/pubmed/35786058 http://dx.doi.org/10.1177/10870547221106238

Ejemplares similares

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD
por: Childress, Ann, et al.
Publicado: (2021)

Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
por: Weiss, Margaret D., et al.
Publicado: (2020)

Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study
por: Childress, Ann C., et al.
Publicado: (2020)

Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults
por: Katzman, Martin A., et al.
Publicado: (2020)

Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension
por: Weiss, Margaret Danielle, et al.
Publicado: (2021)

Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release
por: Weiss, Margaret, et al.
Publicado: (2019)

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety
por: Döpfner, Manfred, et al.
Publicado: (2011)

Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)

Postural Instability in Children with ADHD Is Improved by Methylphenidate
por: Bucci, Maria P., et al.
Publicado: (2016)

The Effect of Methylphenidate on Neurological Soft Signs in ADHD
por: Hrtanek, Igor, et al.
Publicado: (2015)

Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2018)

An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence
por: Rothenberger, Aribert, et al.
Publicado: (2011)

Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment
por: Cambron-Mellott, M Janelle, et al.
Publicado: (2021)

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
por: Engert, Veronika, et al.
Publicado: (2008)

An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes
por: Döpfner, Manfred, et al.
Publicado: (2011)

The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
por: Wienbruch, Christian, et al.
Publicado: (2005)

Methylphenidate significantly improves declarative memory functioning of adults with ADHD
por: Verster, Joris C., et al.
Publicado: (2010)

Comorbidities in ADHD children treated with methylphenidate: a database study
por: Kraut, Angela A, et al.
Publicado: (2013)

Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches
por: Kim, Jae-Won, et al.
Publicado: (2015)

Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate
por: Wolff, Nicole, et al.
Publicado: (2016)

Skin picking disorder comorbid with ADHD successfully treated with methylphenidate
por: Bernardes, Camila, et al.
Publicado: (2018)

Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD
por: D’Aiello, Barbara, et al.
Publicado: (2022)

Alpha/beta-gamma decoupling in methylphenidate medicated ADHD patients
por: Zammit, Nowell, et al.
Publicado: (2023)

Methylphenidate treatment of adult ADHD patients improves the degree of ADHD severity under routine conditions
por: Retz, Wolfgang, et al.
Publicado: (2020)

Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study
por: Ventura, Patrizia, et al.
Publicado: (2022)

Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage
por: Chermá, Maria D., et al.
Publicado: (2016)

Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting
por: Childress, Ann C., et al.
Publicado: (2017)

The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD
por: Natsheh, Joman Y., et al.
Publicado: (2015)

Methylphenidate-Induced Psychotic Symptoms in 65-Year-Old Female with ADHD
por: Ghadrdan, Elliyeh, et al.
Publicado: (2018)

Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD
por: Chuang, Wei-Chen, et al.
Publicado: (2019)

Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients
por: Solleveld, Michelle M., et al.
Publicado: (2017)

Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil
por: Maia, Carlos R., et al.
Publicado: (2015)

Prediction of sleep side effects following methylphenidate treatment in ADHD youth
por: Yoo, Jae Hyun, et al.
Publicado: (2019)

Structural brain network topology underpinning ADHD and response to methylphenidate treatment
por: Griffiths, Kristi R., et al.
Publicado: (2021)

Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD
por: Chang, Jung-Chi, et al.
Publicado: (2021)

How to Predict the Impact of Methylphenidate on Cardiovascular Risk in Children with Attention Deficit Disorder: Methylphenidate Improves Autonomic Dysfunction in Children with ADHD
por: Buchhorn, Reiner, et al.
Publicado: (2012)

P063 Optogenetics for Obstructive Sleep Apnea
por: Knapman, F, et al.
Publicado: (2021)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
por: Huss, Michael, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_krulf0cg6ts4jjuvkhaa274f49